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ABSTRACT
The p53 tumour suppressor is a transcriptional ac-
tivator that controls cell fate in response to various
stresses. p53 can initiate cell cycle arrest, senes-
cence and/or apoptosis via transactivation of p53
target genes, thus preventing cancer onset.
Mutations that impair p53 usually occur in the core
domain and negate the p53 sequence-specific DNA
binding. Moreover, these mutations exhibit a
dominant negative effect on the remaining
wild-type p53. Here, we report the cryo electron mi-
croscopy structure of the full-length p53 tetramer
bound to a DNA-encoding transcription factor
response element (RE) at a resolution of 21 A˚.
While two core domains from both dimers of the
p53 tetramer interact with DNA within the complex,
the other two core domains remain available for
binding another DNA site. This finding helps to
explain the dominant negative effect of p53
mutants based on the fact that p53 dimers are
formed co-translationally before the whole
tetramer assembles; therefore, a single mutant
dimer would prevent the p53 tetramer from binding
DNA. The structure indicates that the Achilles’ heel
of p53 is in its dimer-of-dimers organization, thus
the tetramer activity can be negated by mutation in
only one allele followed by tumourigenesis.
INTRODUCTION
The p53 transcription factor is the major tumour suppres-
sor protein that serves as a gatekeeper of cellular fate in
multicellular organisms (1). p53 is activated in response to
a variety of stress signals and initiates cell cycle arrest,
senescence or apoptosis via pathways involving transacti-
vation of p53 target genes (2–4). This universal protection
of genetic integrity is, however, impaired in many human
cancers, with about a half of them having the p53 gene
inactivated by mutations (5,6). Furthermore, the p53
pathway is very sensitive to the levels of p53 activity and
loss of one of the p53 alleles is sufﬁcient to promote
tumouriginesis as shown in mouse models and patients
with Li–Fraumeni Syndrome (LFS) (7,8).
Unlike other transcription factors, the p53 monomer
has two DNA binding domains instead of one. One of
them, the core domain (residues 98–303), is responsible
for binding to sequence-speciﬁc DNA response elements
(RE) located close to promoters of the p53 target genes
(9). The second DNA binding domain (DBD) in p53 that
maps to its basic C-terminus (CT, residues 323–393)
allows p53 to bind DNA non-speciﬁcally (10,11). p53
exists in cells as a tetramer, or rather as a dimer-of-dimers.
The core domains and CT domains of p53 cooperate in
speciﬁc DNA binding and it has been suggested that the
C-terminus of p53 provides additional anchorage to
speciﬁc DNA sites via non-speciﬁc ﬂanking interactions,
thus stabilising the whole complex (12–15). Deletion of the
ﬁnal 30 C-terminal amino acid residues impairs the stabil-
ity of p53 complexed with long stretches of DNA (13,14)
and p53 efﬁciency as a transcription factor (12). Other
important domains in p53 are the N-terminal (NT) tran-
scription activation domain (TAD, residues 1–67) and the
oligomerization domain, which is a part of CT (OD,
residues 323–363) (16,17).
The main activity of p53 as a transcription factor is
facilitated via its binding to speciﬁc DNA. Two tandem
decameric sequences (so-called half-sites) each comprising
an inverted repeat 50-RRRCWWGYYY-30 (where
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R=purine, Y=pyrimidine and W is either A or T) have
been shown to form a p53 consensus (CON) RE (18,19).
The half-sites can be separated by a spacer of variable
length (typically from 0 to 13 bp) (19,20). Furthermore,
many natural p53 DNA binding elements within p53
target genes are varying in the number of half-sites, with
two of them for p21 and gadd45 REs, three for RGC,
MCK and bax gene REs and four for mdm2 (20,21).
Biochemical experiments demonstrated that p53 binds
speciﬁc DNA as a tetramer, with both dimers thought to
be engaged in the binding (22–24). The structure of the
p53 core domain bound to a speciﬁc DNA explained the
target-speciﬁc mechanism of DNA recognition by p53 (9).
The core domain interacts with DNA and contacts the
phosphate backbone at the centre of the half-site. This
ﬁnding was corroborated by more recent structures of
the p53 core domains in complex with the half-site and
full-size RE (25,26). Due to the properties of the RE, the
core domains of p53 are arranged on DNA with 2-fold
symmetry. A model of p53 based on this structure and on
the fact that p53 is a tetramer in solution suggests that the
four core domains of p53 could simultaneously bind one
RE (9).
While for most tumour suppressors tumourigenesis
requires loss of both alleles, mutation in just one allele
of p53 results in severe loss of function (dominant
negative effect). Thus, transgenic mice expressing
mutated p53 have higher incidence of tumour formation
compared to p53+/ mice (7). Notably, LFS patients with
mutations in the p53–DNA contact residues have a
decreased rate of loss of heterozygosity (LOH), suggesting
that the missense mutation in one allele that produces p53
incapable of binding speciﬁc DNA is sufﬁcient to negate
function of the remaining wild-type (wt) p53 (27).
How the p53 tetramer binds DNA, the spatial arrange-
ment of domains in the p53–DNA complex, the structural
basis for interaction of the protein with the transcription
machinery and the mechanism of the dominant negative
effect of mutant p53 on the overall activity of the protein,
remain to be elucidated. Data obtained by cryo electron
microscopy (EM) and single-particle analysis combined
with X-ray structures of the separate domains of p53 sug-
gested a new quaternary architecture of the whole
tetramer. The cryo EM structure of the full-length
murine protein showed that the p53 tetramer is a hollow
skewed cube whose monomers dimerise via their
juxtaposed NT and CT domains to form N/C nodes
(28). In addition, the structure of a modiﬁed human
full-length p53 tetramer interacting with DNA by EM in
negative stain has been published recently (29,30). A
model of p53–DNA complex based on the latter recon-
struction and the earlier model by Kitayner and
co-authors (26) presented the complex with DNA
‘embraced’ by the four core domains from one side and
a tetrameric bundle of the CT domains positioned at the
opposite side of the DNA. However, this model does not
explain how the DNA contact mutations in the core
domain can negate the activity of the p53 tetramer.
Here, we present the ﬁrst structure of p53 complexed
with DNA containing multiple REs obtained by cryo
EM and single-particle analysis. The full-length
p53–DNA quaternary complex provides new insights
into complex formation and the mechanism of the
dominant negative effect of p53 mutants.
MATERIALS AND METHODS
Recombinant p53 protein and p53–DNA complex
preparation
Recombinant murine p53 was expressed in the baculoviral
system, puriﬁed and tested for homogeneity as described
previously (28). Gels of p53 samples obtained during the
puriﬁcation steps are shown in Supplementary
Figure S1A–1D. To make the DNA fragment comprising
13 consecutive p53 REs we used a HindIII–PstI fragment
of the pG13-CAT plasmid DNA (30) subcloned into a
pBluescript II SK(+) vector (Stratagene), resulting in
pCON13 recombinant DNA. For every experiment
pCON13 was cut with HindIII and PstI restriction
enzymes (Promega) to produce a DNA fragment with
13 CON REs (Figure 1A). The fragment was separated
from the vector backbone by electrophoresis in 0.8%
agarose gel in Tris–Acetate buffer and puriﬁed by extrac-
tion from the agarose block using QIAquick Nucleotide
Removal Kit (Qiagen).
To prepare the p53–DNA complex for electron micros-
copy, 50 ml of p53 were mixed with 5 ml of the CON13
DNA and 45 ml of the binding buffer (100mM NaCl,
25mM Tris–HCl pH 7.5 and 1mM DTT) resulting in
the ﬁnal salt concentration of 125mM. The molar ratio
of CON13 DNA to p53 monomer was 6:4 providing an
excess of REs, so that nearly all p53 should be bound to
DNA. The mixture was incubated for 20min at room tem-
perature with further incubation on ice for 30min.
Electron microscopy
Negative staining. Samples were applied to carbon-coated
copper grids (C-ﬂat grids, R2/2, Protochips, Raleigh, NC,
USA) and negatively stained with 2% uranyl acetate in
order to ﬁnd the best conditions for DNA binding
(Supplementary Figure S2A). Images were taken in a
JEOL 2200FS EM at 200 keV and a nominal magniﬁca-
tion of 40 000. Images were recorded with low electron
dose (10–20 electrons/A˚2) using Kodak SO163 photo-
graphic ﬁlm and digitized using Zeiss SCAI scanner with
a pixel size of 14 mm corresponding to 3.5 A˚/pixel on the
specimen scale.
Rotary shadowing. To preserve binding of p53 to DNA,
0.1% glutaraldehyde was added to the mixture. The p53–
DNA complexes were allowed to adsorb to freshly cleaved
mica for 2min. They were stained with 2% uranyl acetate
for 2min followed by three washes in water. Air-dried
mica was rotary-shadowed with Pt-Ir alloy at an angle
of 4–7 followed by carbon evaporation in an Edwards
Coating System (E306A) (31). Grids were examined in a
FEI CM 100 EM; images were taken with 1 k 1 k TVIPS
F114 slow-scan CCD camera at 11 500 nominal EM
magniﬁcation (Figure 1B–D).
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Cryo EM. Sample vitriﬁcation was done on holey carbon
ﬁlms (R2/2 Quantifoil or C-ﬂatTM). Samples were
applied to the grids and examined in a JEOL 2200FS
EM, equipped with an in-column energy ﬁlter (omega
type) at 200 keV. The images were recorded under low
electron-dose conditions (10–20 electrons/A˚2) with a
4 k 4 k slow-scan CCD camera (UltraScan 895,
GATAN, Inc.) at a nominal EM magniﬁcation of
50 000 (pixel size of 2.33 A˚/pixel) or 80 000 (pixel size
of 1.5 A˚/pixel) (Figure 1E). A range of defocus values
varying from 1.5 to 5.5mm was used for data collection.
Image processing
About 15 000 particle images were selected from 467 CCD
frames. The particle images were picked manually using
the BOXER program from the EMAN package (32).
The main criterion for the DNA bound p53 particle
picking was based on distances between the particles:
they should be in close proximity to each other, but at
the same time far enough apart to avoid overlapping.
Single p53 particles that were distant from each other
were less likely to have bound to DNA (because of the
speciﬁc DNA construct used in the experiment) and were
not selected for image processing. The contrast transfer
function of the microscope (CTF) was corrected in the
dataset using CTFFIND3 program by phase ﬂipping
(33). The images were then normalized to the same
mean and standard deviation and were band-pass
ﬁltered to remove uneven background and high frequency
noise (with low- and high-resolution cut-offs of 90 A˚ and
12 A˚, respectively).
E
200 Å
C
500 Å
DB
A
CON13
Half-site
5’ – RRRCW WGYYY – 3’
CON DNA
(RE)
260 bp (~900 Å)
10 bp (~35 Å)
20 bp (~70 Å)
Figure 1. EM of p53–DNA complexes. (A) Schematic representation of the DNA with 13 consecutive CON (RE) sequences used for p53–DNA
binding experiments. (B–D) EM images of p53–DNA complexes rotary shadowed with Pt-Ir. White and black arrows show DNA and p53,
respectively. (D) In these images, a single-p53 tetramer is seen bound to two DNA strands. Scale bars 500 A˚. (E) Cryo EM images of p53–DNA
complexes showing that the DNA-bound protein particles resemble ‘beads on a string’. Circles indicate p53 tetramers attached to DNA (grey line).
Scale bar 200 A˚.
8962 Nucleic Acids Research, 2011, Vol. 39, No. 20
Alignment and classiﬁcation were performed using
IMAGIC-5 software (34). The classes obtained repre-
sented characteristic views of the p53–DNA complexes.
The relative angular orientations of class average images
were determined by angular reconstitution (35). Three-
dimensional maps were calculated using the exact-ﬁlter
back projection algorithm [(35) and references therein].
An ab-initio map was calculated using approximately
100 classes. The quality of the maps obtained was
assessed using different parameters: minimization of
errors in the angular search, errors between input classes
and corresponding reprojections of the model, and ﬁnally
by the Fourier Shell Correlation [(35) and references
therein]. Since the DNA properties enforce symmetry in
the p53 binding to the CON sequences, we used 2-fold
symmetry in our analysis. Representative class averages
and reprojections from the reconstruction are shown in
Supplementary Figure S2B. We performed more detailed
classiﬁcation by increasing the number of classes and
reducing the number of images per class with the progres-
sion of the reﬁnement. Seven hundred best classes
(10 images/class) were used in the ﬁnal reconstruction.
The classes were selected based on their correlation with
the reprojections of the model. Distribution of angular
orientations is shown in Supplementary Figure S2C. The
resolution of the ﬁnal reconstruction was estimated to be
21 A˚ using 0.5 Fourier Shell Correlation conservative
criterion between two half data sets (35) (Supplementary
Figure S2D). The ﬁnal map was then low-pass ﬁltered to
that resolution.
Alignment of EM maps, subunit docking and visualization
Rotational and translational alignments of the different
maps: DNA free (28) at different orientations,
DNA-bound EM maps and the published structure
obtained from negatively stained p53–DNA complexes
(36), were performed using Chimera (37). Fitting of
atomic models was performed using Chimera and Veda/
UROX [http://mem.ibs.fr/Veda/, (38)].
For the docking, we used atomic coordinates of human
p53 [PDB: 2ata for the core domain (26), 1c26 for the
tetramerization domain (39); model coordinates of the
N-terminal domain were kindly provided by Dr A.
Vema (Uppsala University, Sweden). We used atomic
models of the human p53, since hp53 is 77% identical to
mp53 in sequence. To avoid being trapped in local minima
we used several starting positions and orientations of the
core models in ﬁtting. In addition, we used two different
programs for independent ﬁtting. The ﬁtting results with
the highest cross-correlation coefﬁcients (CCC) are shown
in Supplementary Figure S3. The difference in the ﬁts
obtained by the two programs was about 2.5 A˚ in shift
and 3 in rotation which indicated a good conﬁdence
of the ﬁtting at the resolution of 21 A˚. The same procedure
was repeated for the positioning of NT and CT domains
with Veda: the ﬁt with fewer steric clashes and best CCC
(0.75) was considered as the ﬁnal one. Shifts and rota-
tions of ﬁtted core domains were assessed using CCP4
software (40).
Illustrations were generated using PyMOL (http://
pymol.sourceforge.net/). Surface rendering was performed
using a threshold level of 2 standard deviations (2s) in
the maps corresponding to 100% of the expected mass
of the complex. The threshold was determined assuming
that a mass of the complex of 240 kDa and a speciﬁc
protein density of 0.84 kDa/A˚3. Higher densities are
shown at the threshold of 3s.
RESULTS
EM of the p53–DNA-speciﬁc complex
For a reliable selection of DNA bound p53 particles, we
used a DNA target with several contiguous p53 binding
sites. This allowed us to select the complexes not only by
visual inspection but also using additional criteria, e.g.
relative distances and positions of the particles. We used
a DNA template with thirteen consecutive p53 CON REs
(Figure 1A). Complex formation was tested by rotary
shadowing techniques and negative stain, both of which
showed protein particles attached to DNA as ‘beads on a
string’ (Figure 1B and C, Supplementary Figure S2A).
Images revealed p53–DNA complexes with 3–4 protein
particles attached to DNA fragments. p53 tetramers
were attached to DNA with intervals of 100 A˚ or
longer. Apparently, steric hindrance of the tetramers pre-
vented them from binding to every RE present in the
DNA: the p53 particles were 90 A˚ across and the
length of a single repeat was 20 bp (70 A˚) which is too
close for p53 to bind adjacent repeats. At low concentra-
tions of p53 one can see that DNA is attached to the side
of individual p53 tetramers (arrowheads, Figure 1C). We
also obtained images in which two strands of DNA were
attached to a single p53 tetramer (Figure 1D). This
pointed to either the DNA looping or the p53 tetramer
hopping between different DNAs.
3D structure of p53–DNA-speciﬁc complex
The p53–DNA complexes were examined by cryo EM
(Figure 1E) to study in detail the 3D organization by
image analysis. The overall shape of the p53–DNA
complex could be described as a globular mass attached
to a stem (Figure 2A). Analysis of the molecular shape
and connectivity in the p53–DNA complex images sug-
gested that the stem and the globule would represent
DNA and p53, respectively. The p53 tetramer has
overall dimensions of 75 80 85 A˚ and is hollow
inside, which is consistent with our previous reconstruc-
tion (28). The structure has four high density nodes within
the protein globule arranged with pseudo D2 symmetry;
the complex had openings 15 A˚ diameter on each face.
A pair of the denser nodes in the tetramer bound to the
stem was 27 A˚ in diameter (Figure 2D). Comparison of
the 3D maps of the p53–DNA complex with our previous
reconstruction of the p53 tetramer implies that the stem
density can be attributed to the DNA and that the DNA is
bound to the side of the tetramer and does not thread
through the p53 assembly (Figure 2A). This is in agree-
ment with images of rotary shadowed p53–DNA
complexes (Figure 1B and C).
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Fitting of the atomic structures into the cryo EM map of
the p53–DNA complex
The high protein density nodes bound on opposite sides of
the density corresponding to DNA have deﬁned handed-
ness of the structure since they were shifted relative to
each other along the DNA. The best ﬁt of the atomic
structure [PDB 2ata, (26)] into our cryo EM map of the
p53–DNA complex is shown in (Supplementary Figure
S3) along with CCC. While CCCs for the mirrored maps
were only slightly lower than those for the best ﬁt, the dir-
ections of the DNA in them did not correspond to the
direction of the elongated density in the reconstruction.
Since the length of DNA in the atomic model (PDB
code 2ata) corresponded to only one half-site of RE, we
performed additional docking tests using longer stretches
of the DNA (twice as long), which were still well within
the size of the reconstructed p53–DNA volume allowing
us to avoid bias towards elongated density of the stem. In
this case the differences in the CCC values for different ﬁts
became more prominent making the determination of the
structure handedness clearer (Supplementary Figure S3).
The part of our map close to the DNA density was in
good agreement with the X-ray structure of the p53 core
domains bound to speciﬁc DNA (2ata) and allowed us to
verify the hand of the complex (Figure 2C). The automatic
A
80 Å
10
5 
Å
84
 Å
155 Å
Core
N/C
Core
C/N Core
Core
N/C
C/N
B
C
D
Core
Core
Core
Core
CoreCore
Core Core
Figure 2. 3D reconstruction of the p53–DNA complex. (A) Side and top views of the p53–DNA complex. (B) Superimposition of the DNA-free p53
map (gold) on the p53–DNA complex map (blue–grey). The two maps were compared in order to determine the location of core domains and dimers
within the complex. N/C—areas of N- and C-termini interaction. The length of the stem corresponding to DNA is limited by the size of the image
frames. (C) Stereo view of the crystal structure of two core domains bound to DNA RE (PDB entry: 2ata) ﬁtted into the upper part of the map
(threshold used: 2s, light grey). Core domains are displayed in orange and DNA in red. (D) Fitting of the core domains and DNA in the EM map.
Core domains are displayed in blue and red, DNA in orange. The high EM densities are shown in light blue at 4s. Fits were performed with both
Chimera and Veda/UROX. The best ﬁts from each software produced similar results.
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ﬁtting of the other two core domains into remaining high
density areas of the EM map distal from DNA suggested
that the four dense nodes corresponded to the core
domains and were arranged with pseudo-D2 symmetry.
In this interpretation, the two core domains were in
direct contact with DNA, whereas the other two did not
participate in DNA binding.
Alignment of the DNA free and DNA-bound p53
EM maps
We have compared our two cryo EM maps using
cross-correlation analysis at their different orientations
relative to each other. The comparison has revealed two
possible orientations for the p53-tetramer map in the new
p53–DNA complex map with high correlation scores. One
of them is shown in Figure 2B (CCC=0.64), the other
one with slightly lower CCC (0.63) corresponds to the
mirrored map. Although CCCs for both ﬁts were quite
similar to each other, details in them were different.
These results prompted us to revise our former ﬁt of the
core domains into p53 tetramer (28). The orientations of
core domains ﬁtted into our new map of p53–DNA
complex differed from the model of DNA-free p53; in
the new ﬁt the cores were rotated so that Zn-ﬁngers and
short H1 helices pointed inwards. This new position of
core domains has a signiﬁcantly improved correlation of
the ﬁt and is consistent with p53–DNA interactions
demonstrated by the X-ray structure. Since the orienta-
tions of cores should not radically change upon DNA
binding, it was logical to revise the previous model of
the p53 tetramer. The rotated core domains did not
change the overall shape of the p53 tetramer or the
general concept of its dimer/dimer organization but
made the model consistent with that of the p53–DNA
functional complex (Supplementary Figure S4).
We have tested the orientation of the atomic models of
the core domain in the aligned tetramer structure in both
possible ﬁts of the DNA-free map into the p53–DNA
complex. While a ﬁt into the original map produced a
CCC of 0.75, docking into the mirrored version gave a
signiﬁcantly lower CCC of 0.50. We therefore considered
the orientation of the p53 tetramer within the map of p53–
DNA complex shown in Supplementary Figure S4A to be
the best ﬁt.
Alignment of the DNA-free p53 tetramer (28) with the
map of the p53–DNA complex suggested that the dimers
within the tetramer are oriented in such a way that only
two cores (one from each dimer) interact with DNA, while
the other two core domains are free to bind another distal
RE (Figure 2B–D).
Analysis of p53–DNA interactions
The globular shape of the p53 tetramer and the relatively
low resolution of the structure did not allow an unambigu-
ous assignment of the core domains to speciﬁc dimers
within the tetramer. We therefore analysed two possible
modes of DNA binding by p53, both satisfying the
observed arrangement of the core domains with pseudo
D2 symmetry. In one case both cores of the same dimer
bind the DNA [Figure 3A(i)], while the cores of the
other dimer face away from it. Alternatively, each of the
two dimers can donate one core to bind DNA, so that
both dimers are engaged in the interaction. The latter
arrangement can be accomplished with two different
orientations of the dimers relative to the DNA: the
plane of each dimer can be either almost parallel
[Figure 3A(ii)] or nearly perpendicular to the DNA helix
axis [Figure 3A(iii)].
We compared distances between DNA binding elements
in p53 to assess possible conformational changes required
for DNA binding. The model shown in Figure 3A(i) can
be ruled out since the distance between the cores in that
model (mainly between loops and helices that are
supposed to interact with DNA) is 75 A˚, while in the
p53–DNA complex it corresponds to 27 A˚. Such a signiﬁ-
cant rearrangement would require dramatic conform-
ational changes, which is unlikely. The distance between
DNA binding elements in the narrow dimension of the
p53 tetramer [corresponding to the model orientations
shown in Figure 3A (ii and iii)] is 40 A˚, which is much
closer to 27 A˚ and could be adjusted to the distance in the
bound state by rotation and small shifts of the cores.
The orientation of the C-terminus of the core (Ctc)
represented by the alpha helix interacting with DNA
(Figure 4A, 2ata, ref. 26) allows the CT to go either to
the same side of the DNA helix [model Figure 3A (ii)] or
to go across the DNA helix [model Figure 3A (iii)]. The
Ctc’s position of the core domain does not allow the pro-
tein chain to cross underneath the DNA. For the binding
shown in Figure 3A iii to occur the dimer would have to
dissociate and then re-associate. In addition, we did not
see any protein densities in the reconstruction above the
DNA. We therefore concluded that the model shown in
Figure 3A ii is the only one that would ﬁt all the experi-
mental data.
Comparison of the p53–DNA complex with our recent
reconstruction of p53 tetramer 3D maps and ﬁtting of the
atomic model 2ata suggested that both of the p53 dimers
interact with DNA and the dimers were oriented parallel
to the DNA axis in agreement with the model shown in
Figure 3A ii. The orientations of the DNA-bound core
domains in the complex allowed us to localize CT and
NT domains within dimers and to deﬁne the positions of
the dimers (Figure 3B and C). The ﬁt of the CT domains
has demonstrated that they are localized within the DNA
contact regions providing additional interactions with
DNA, thus enhancing the complex stability (Figure 3B
and C). On the other hand, the NT domains are located
further away from DNA and do not participate in the
p53–DNA complex formation but have room to interact
with other proteins of the transcriptional machinery.
p53 domain rearrangement upon DNA binding. We next
examined structural changes in p53 induced by DNA
binding. Comparison of the DNA-free tetramer and the
complex suggested that the two dimers within the p53
tetramer rotate by 45 relative to each other upon
binding to DNA (Figure 4A and B). The rotation brings
the two core domains closer to each other allowing them
to interact with DNA. Rotation of the dimers caused a
shift of the core nodes by 15 A˚ (Figure 4A) As a result of
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this rearrangement, the N/C nodes from different dimers
also move into new positions, which puts the C-termini of
the interacting side closer to DNA and the N-termini into
a position that presumably would be favourable for inter-
action with components of the transcriptional machinery.
DISCUSSION
p53 is a transcriptional activator that plays a pivotal role
in control of gene expression and cell fate responding to
various genotoxic stresses. p53 is highly conserved among
higher eukaryotes and performs many functions utilizing
its unique architecture. This ‘one molecule–many func-
tions’ paradigm is provided by an intrinsically ﬂexible
quaternary organization of p53 (21,41,42).
Several 3D reconstructions of negatively stained,
modiﬁed human p53 bound to DNA have been published
in recent years (29,30,36). The latest EM structure of a
human p53–DNA complex in negative stain is more ﬂat-
tened compared to the maps obtained from our cryo
sample preparations and does not reveal the DNA (30).
The ﬂattening could result from the sandwich technique
used for the sample preparation, where the specimen is
placed between two layers of carbon ﬁlm (43). The
absence of DNA in the map of the human p53–DNA
complex could be explained by low occupancy of DNA
in the dataset due to the difﬁculty of observing DNA in
the images (30,36), the ﬂexibility of DNA ends obscuring
its visibility in averaged images and a relatively strong
A
B
C
Figure 3. Structural organization of the DNA-p53 complex. (A) Each dimer is depicted as a rectangular plane that packs face-to-face to form the
p53 tetramer. Three possible arrangements of the interaction of this p53 tetramer with DNA are shown: (i) in this arrangement only the two core
domains of the blue dimer interface with DNA (orange rod). In (ii) and (iii) domains from two different dimers (blue and red) interact with DNA,
but in two possible conﬁgurations: in (ii) the shorter edges of the rectangular dimers are oriented along the DNA helix whereas in (iii) the DNA helix
lies across these edges. Positions of N- and C-termini, indicated as N and C accordingly, are shown as light and dark rods of the same colour along
the edges of the dimer planes. (B and C) Stereo views of p53 dimers within the map, corresponding to model (ii). The dimer at the front is in blue,
and at the back is in red, and the DNA in orange. The positions of the N- and C-termini are shown in different shades of blue. Two of the C-termini
domains are located just below the DNA, and the other two are at the bottom of the structure. Positions of C-termini in the core domains are
indicated with Ctc.
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background in images resulting from the two layers of
carbon.
We have compared the map of human p53 bound to
DNA (kindly provided by JM Carazo, ref. 36) with our
reconstruction of murine p53–DNA complex
(Supplementary Figure S5). The dimensions of the
complexes were similar. The four high density nodes cor-
responding to the core domains in our map co-locate with
the major densities in the human p53–DNA map.
Therefore, the overall architecture of the complexes
could be related. However, due to the absence of DNA
in the human p53–DNA map the interpretation of the
map remains uncertain.
Our analysis of the ﬁrst cryo EM 3D structure of the
full-length p53 transcription factor in complex with its
speciﬁc DNA at 21 A˚ resolution provides new insight
into the structure–function relationship of p53. The struc-
ture obtained under cryo conditions clearly reveals DNA
and this was conﬁrmed by images obtained by rotary
shadowing. The cryo EM structure demonstrates how
the full-length p53 tetramer binds its speciﬁc DNA using
both dimers. The dimers contribute one core domain each
to bind the RE. The densities of the map corresponding to
core domains bound to DNA in the EM map are in good
agreement with the atomic structures of both human and
Figure 4. Rearrangement of domains within the p53 tetramer upon DNA binding. (A) Stereo (side and front) views of a superposition of one top
core domain from the p53–DNA complex EM map (blue) and the core from an aligned DNA-free EM map (yellow). The relative rotation between
the cores is shown with a red arrow. (B) Schematic representation of p53 in the DNA-free state (left) and DNA-bound complex (right). In the
DNA-free state the p53 tetramer is represented as a pair of red and blue dimers. When interacting with speciﬁc DNA sequences the two dimers rotate
relative to each other (red and blue arrows, left panel) bringing the upper two core domains closer to enable interactions with DNA.
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murine p53 core domains bound to their cognate DNAs
(Figure 3) (26,44).
p53 interaction with DNA
Previous reports indicated that in search for its speciﬁc
DNA site, p53 is able to slide along DNA and the CT
domain of p53 is required for this mechanism (14,15,45).
Therefore, it has been proposed that p53 initially binds
DNA non-speciﬁcally using its CT and core domains
and then translocates along the DNA to the RE site
where the core domains facilitate the speciﬁc binding
(15,45).
Since core domains are poised for interaction, it would
be easy for the tetramer to form a stable complex with the
speciﬁc DNA sequence by undergoing a rotational re-
arrangement with the CT domains helping the cores to
form a stable complex. Our results indicate that the p53
tetramer binds only a half-site of its consensus RE using
just two core domains, which is consistent with previous
reports (20,22,23,42). Upon binding, the core domains
shift by 15 A˚ with an accompanying rotation by 45.
These movements are consistent with adjustment of the
DBDs in other DNA binding proteins. For example, the
catabolite activator protein (CAP) accommodates its
DBD orientations upon interaction with high afﬁnity
sites of DNA, whereupon the DBD in CAP undergoes a
shift of 7 A˚ and rotation of 60 (46). Another example is
the ﬂexible transcriptional regulator CprK which on inter-
action with DNA and its ligand leads to a reorganization
and re-orientation of the DBDs (47).
The symmetrical organization of p53 would certainly
allow the screening of the DNA and its translocation to
other DNA segments. The position of C-terminal domains
would be the key to this fast translocation mechanism as
they are considered to be essential for recognition of
non-speciﬁc DNA sequences. In our cryo EM structure
of the complex, there are two CT and two core domains
that interact with DNA in close proximity forming a large
DNA binding interface. This suggests that the CT and
core domains of p53 could initially interact non-
speciﬁcally with DNA, allowing the tetramer to slide
along DNA until a RE site is found (48). Association/dis-
sociation events and the sliding of p53 along a DNA
ﬁlament were visualized by AFM (48). While interacting
with non-speciﬁc sequences, p53 may adopt a different
conformation from that described in this article. Direct
transfer of p53 between different DNA segments and the
search for REs in the context of chromatin, would be
greatly facilitated by the symmetry of the p53 tetramer.
p53 tetramer architecture and DNA looping
Previous electron and atomic force microscopy studies
demonstrated that a single-p53 tetramer is enough to
loop DNA containing several RE sites separated by at
least 150 bp (49–51). Simultaneous speciﬁc binding of a
single-p53 tetramer to two separate REs would be
possible if the pairs of core domains located at the
opposite sides of the tetramer were both engaged in
DNA binding, leading to the so-called ‘sandwich model’
(52). The p53 tetramer organization determined in our
study is consistent with this model in which the pairs of
core domains on either side of the tetramer can each bind
one RE. This is supported by our imaging of the p53–
DNA complex using rotary shadowing (Figure 1D),
where one p53 tetramer is attached to two separate
DNA strands. Therefore, if two p53 REs are separated
by a sufﬁciently long DNA stretch or two different
DNA molecules are in close proximity, both pairs of
cores of p53 would be available for simultaneous
binding (Figure 5A). It is also consistent with the ability
of p53 to synergistically transactivate promoters by
looping DNA and linking distal p53 REs, as previously
demonstrated in vivo (51).
Dominant negative effect of p53 mutants
A major function of p53 in regulation of the cell cycle is
tumour suppression. Thus p53 is often a prime target
when a cell undergoes neoplastic transformation.
Moreover, missense mutations in one allele of p53
dominate over the wt allele, resulting in a phenotype
characterized by severe reduction or complete negation
of the remaining wt p53 activity (53–55). It has not been
clear so far, how missense mutations that impair p53–
DNA interaction could produce such a profound
dominant negative effect. One would expect that a
cancer cell having one p53 allele hit by a DNA-contact
mutation would lose the remaining wt allele through the
LOH of p53, similar to LFS cases with structural and
deletion mutations of p53 (8,27). However, the cancer
hotspot mutations that impair DNA binding of p53 are
often characterized by the decreased rate of LOH
(27,54,56).
We consider that our reconstruction of the p53 tetramer
bound to DNA helps to explain the dominant negative
effect of missense mutations on the tumour suppression
by p53. Our structure implies that the p53 tetramer binds
to its speciﬁc DNA using both of its dimers, which means
that one mutant dimer present in the tetramer would be
enough to abolish the binding and to negate the transcrip-
tion activation function of p53 (Figure 5B). Importantly,
an earlier study by Nicholls and co-authors (24)
demonstrated that p53 dimers are formed
co-translationally resulting in either mutated or the wt
homo-dimers. Thus tetramers are formed post-
translationally by dimerization of the existing dimers.
The co-translational dimer production and synchronized
participation of the dimers in the p53 speciﬁc DNA
binding would make the effect of a missense mutation
far more severe compared to the scenario where p53
core domains interact with DNA independently within
the p53 tetramer (29). Just one mutated p53 allele would
inactivate 75% of p53 tetramers, which would have a
devastating effect on tumour suppression (Figure 5B).
This would also be consistent with the fact that
co-translated wt and mutant p53 dimers form tetramers
incapable of binding speciﬁc DNA and that the oligomeric
mutants of p53 are inefﬁcient as transcription factors
in vivo (24,57). Moreover, mutant p53 exerts its
dominant negative effect by preventing p53 tetramers
from binding to the promoters of its target genes, the
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effect that would be expected if the majority of p53 tetra-
mers were composed from a mixture of wt and mutant
proteins or just from mutant version of p53 (Figure 5B)
(57,58). A drastic reduction in the p53 activity would then
open the gate for a tumourigenic process without a need
for LOH, thus consistent with data obtained from mouse
models and LFS patients (53–55).
CONCLUSIONS
Here we report the ﬁrst molecular structure of a speciﬁc
p53–DNA complex solved by cryo EM and single-particle
analysis. Analysis of the functional p53–DNA complex
allowed us to resolve the ambiguity of the domain orien-
tations within the map improving the pseudo-atomic
model of the complex. Although the relatively low reso-
lution of the map makes it difﬁcult to deﬁne precise pos-
itions of individual p53 domains relative to the DNA,
these results together with biochemical and crystallo-
graphic evidence (14,15,26,58) provide a conceptual
platform for understanding the p53 function through its
architecture, speciﬁc DNA binding and the structural
basis for the dominant negative effect of p53 mutants.
The mechanistic model suggests that the function of the
p53 tetramer critically depends on both of its dimers
acting in concert to bind the DNA. Upon binding to
DNA, the p53 dimers rotate slightly relative to each
other and contribute one core domain each to the DNA
interface. This re-arrangement allows the CT domains to
stabilize the complex, while the NT domains are brought
into position to facilitate interaction with the components
of transcription machinery.
The architecture of the p53 molecule is consistent with
its multiple functions. At the same time the p53 quater-
nary organization is its Achilles’ heel. The missense muta-
tions that inactivate one p53 allele produce mutant p53
dimers which, when oligomerized with the wt p53 dimers,
dramatically decrease the overall p53 activity. Thus when
at least one of the dimers is compromised by a mutation,
the p53 tumour suppressor is put out of action leading to
the loss of function and ultimately to tumourigenesis.
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Figure 5. p53 DNA binding and the effect of mutations. (A) Schematic
representation of DNA looping by p53. Two distal REs are bound to
two pairs of cores located on opposite sides of a single-p53 tetramer.
(B) Suppression of p53 activity by cancer-associated mutations. As p53
dimers are formed co-translationally (24), half of the dimers would be
of wt with both core domains active (open circles) and the other half
would be inactive dimers, with mutated core domains (shaded circles).
If both dimers are translated at equal levels, they could form three
different types of tetramers with corresponding probabilities: 25% wt/
wt, 50% wt/mut and 25% mut/mut. In our structure, where each dimer
within the p53 tetramer contributes one core domain to speciﬁc DNA
binding, only one type of tetramer (wt/wt) would be functional.
Therefore once one allele of p53 is mutated in the DNA binding
region, it would render inactive 75% of p53 tetramers, which is in
agreement with observed in vivo dominant negative effect of p53 mu-
tations (48).
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